STOCK TITAN

Marker Therapeutics, Inc. (MRKR) Revenue by Year

MRKR

Marker Therapeutics, Inc. generated $3.5M in revenue in fiscal year 2025. This represents a decrease of 46.2% from the prior fiscal year. The table below carries 15 fiscal years, from 2011 to 2025, and the quarters Marker Therapeutics, Inc. has filed alongside them.

FY2025 annual
Revenue $3.5M
YoY -46.2%
5Y CAGR +48.0%
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD

Annual figures, oldest first. Point at a bar to read its period.

MRKR Revenue by Fiscal Year

Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.

MetricFY2510-KFY2410-KFY2310-KFY2210-KFY2110-KFY2010-KFY1910-KFY1810-KFY1710-KFY1610-KFY1510-KFY1410-KFY1310-KFY1210-KFY1110-K
Revenue$3.5M-46.2%$6.6M+99.1%$3.3M-5.8%$3.5M+183.0%$1.2M+148.3%$500K+134.5%$213K+3.5%$206K+12.5%$183KN/AN/AN/AN/AN/AN/A

MRKR Revenue by Quarter

Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.

MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-QQ2'2410-QQ1'2410-QQ4'2310-KQ3'2310-Q
RevenueN/A$752K+115.3%$1.1M-51.0%$1.2M-36.0%$861K-26.3%$349K-71.9%$2.3M+113.1%$1.9M+647.7%$1.2M+53.3%$1.2M+0.8%$1.1M+39.2%$258K-74.2%

What revenue means

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it.

More Marker Therapeutics, Inc. financials

Frequently Asked Questions

What was Marker Therapeutics, Inc.'s revenue in fiscal year 2025?

Marker Therapeutics, Inc. generated $3.5M in revenue in fiscal year 2025.

How fast is Marker Therapeutics, Inc.'s revenue growing?

Marker Therapeutics, Inc. (MRKR) revenue fell by 46.2% year over year, from $6.6M to $3.5M in fiscal year 2025.

What does revenue mean on a financial statement?

Revenue is everything the company billed its customers over the period, counted before any cost of running the business comes out of it. This page lists what Marker Therapeutics, Inc. (MRKR) reported on that line in every period on record.